Blood Pressure Control Target in Diabetes
American College of Cardiology
NOVEMBER 16, 2024
The goal of the BPROAD trial was to determine the efficacy and safety of an intensive blood pressure (BP)-lowering strategy in patients with type 2 diabetes mellitus (T2DM) and hypertension with respect to future cardiovascular disease (CVD) events.
Let's personalize your content